Epidemiology & Risk Factors

  • Exogenous (most common):
    • Postoperative ocular surgery: Cataract extraction (most common trigger, typically within 1–2 weeks post-op).
    • Trauma: Penetrating ocular injury, retained intraocular foreign body.
    • Intravitreal injections (e.g., anti-VEGF for AMD).
  • Endogenous:
    • Hematogenous spread from distant focus (e.g., infective endocarditis, indwelling CVC, IVDU).
    • Immunocompromised status, prolonged TPN.
  • Common Pathogens:
    • Coagulase-negative Staphylococci (e.g., S. epidermidis — most common post-op).
    • Staphylococcus aureus, Streptococcus spp.
    • Gram-negative bacilli (e.g., Pseudomonas aeruginosa).
    • Candida albicans (most common endogenous agent, especially in IVDU/TPN).

Clinical Features

  • Symptoms:
    • Rapidly progressive visual loss / decreased visual acuity (VA).
    • Significant ocular pain and photophobia (can be mild in indolent coag-negative Staph).
    • Redness, floaters, eyelid swelling.
  • Physical Exam:
    • Hypopyon (layering of WBCs in anterior chamber).
    • Vitritis: Vitreous haziness, loss of red reflex, obscured fundus visualization.
    • Conjunctival injection and chemosis.
    • Corneal edema, ciliary flush.
    • Endogenous Candida: Funduscopic exam reveals focal white, fluffy, chorioretinal lesions extending into the vitreous (“string-of-pearls” appearance).

Diagnosis

  • Initial / Clinical:
    • Urgent slit-lamp biomicroscopy & dilated fundus exam demonstrating anterior chamber reaction and vitreous exudates.
  • Confirmatory / Gold Standard:
    • Vitreous tap / biopsy (or anterior chamber paracentesis): Gram stain, bacterial/fungal cultures, and PCR.
  • Key Labs:
    • Blood cultures (mandatory if endogenous source suspected).
    • Fungal biomarkers (e.g., 1,3-β-D-glucan) if endogenous fungemia suspected.
  • Imaging:
    • B-scan ocular ultrasound: Indicated when dense vitritis/corneal edema precludes direct fundus visualization (evaluates vitreous debris, choroidal thickening, retinal detachment).

Differential Diagnostics

  • Toxic Anterior Segment Syndrome (TASS):
    • Diff: Sterile post-op inflammatory reaction presenting within 12–24 hours (vs. days to weeks in endophthalmitis); vitreous is clear; responds rapidly to topical steroids.
  • Acute Anterior Uveitis (Iritis):
    • Diff: Leukocytes confined to anterior chamber; normal red reflex and clear vitreous; no history of intraocular surgery/trauma.
  • Acute Angle-Closure Glaucoma:
    • Diff: Markedly elevated IOP (>40–50 mmHg), fixed mid-dilated pupil, “steamy” cornea, headache/nausea; absent hypopyon/vitritis.
  • Bacterial Keratitis (Corneal Ulcer):
    • Diff: Infection limited to corneal stroma with overlying epithelial defect visible on fluorescein staining; intraocular vitreous initially uninvolved.
  • Orbital Cellulitis:
    • Diff: Extraocular muscle restriction, painful ophthalmoplegia, proptosis; internal eye structures (vitreous/retina) are clear.

Management

  1. Immediate Step:
    • Emergent Ophthalmology consultation (vision-threatening emergency).
  2. First-line Medical Therapy:
    • Intravitreal empiric broad-spectrum antibiotics:
      • Vancomycin (Gram-positive coverage) + Ceftazidime or Amikacin (Gram-negative coverage).
    • If fungal etiology suspected/confirmed:
      • Intravitreal Amphotericin B or Voriconazole + systemic antifungals (e.g., IV/PO Voriconazole or Fluconazole).
    • Adjunctive therapy: Topical cycloplegics (for ciliary spasm/pain) and delayed topical corticosteroids (to reduce inflammatory damage after Abx initiated).
  3. Procedural / Refractory:
    • Pars Plana Vitrectomy (PPV):
      • Indicated immediately for patients with profound vision loss (light perception only or worse, per EVS guidelines).
      • Indicated for retained intraocular foreign body, fungal endophthalmitis, or clinical deterioration despite intravitreal Abx.

Complications

  • Permanent vision loss / blindness.
  • Retinal detachment.
  • Panophthalmitis (extension beyond intraocular space to entire eyeball/orbit).
  • Phthisis bulbi (atrophic, non-functioning, shrunken eye).
  • Enucleation or evisceration.